Video

Amy Dowd Outlines beWellnm's Year 3 Open Enrollment Strategy

After beWellnm lost a major state insurer, the exchange changed its enrollment strategy and traveled throughout New Mexico to discuss the change in the market and remind the population about the assistance available, explained Amy Dowd, CEO of beWellnm.

After beWellnm lost a major state insurer, the exchange changed its enrollment strategy and traveled throughout New Mexico to discuss the change in the market and remind the population about the assistance available, explained Amy Dowd, CEO of beWellnm.

Transcript (modified)

How did beWellnm have to adjust its enrollment strategy after losing one of the state’s biggest insurers?

That was a big change for year 3: half of the exchange enroll population, through bewellnm.com, lost their health insurance plan. Their insurance plan was discontinued, so they had to find a new plan in order to maintain their coverage.

So 2 things we did with our strategy this year: I went out with the superintendent of insurance and we did a roadshow across the state. We spent most of the month of October meeting with consumers, and agents, and brokers, and talking about this very significant change in the market. So that was one thing that we did. And then we integrated into all of our messaging and our marketing and our outreach efforts the fact that, if you are someone who has a discontinued plan, you need to take action; there’s lots of free assistance available and it was very important that you take action in order to retain your health insurance for 2016.

Related Videos
dr jennifer green
Lalan Wilfong, MD, during a video interview
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
dr ken cohen
Ana Baramidze, MD, PhD
Eva Otter, president of PHA Europe
Samyukta Mullangi, MD, MBA.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine, The University of Manchester
Wanda Phipatanakul, MD, MS, professor of pediatrics, Harvard Medical School; director of the Clinical Research Center, Boston Children's Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Related Content
CH LogoCenter for Biosimilars Logo